Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.

Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE, Ahn K.

J Immunol. 2000 Jan 15;164(2):805-11.

3.

The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.

Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, Früh K.

Immunity. 1997 May;6(5):613-21.

4.
5.

Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.

Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ.

J Immunol. 2003 Dec 15;171(12):6757-65.

6.

Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.

Pande NT, Powers C, Ahn K, Früh K.

J Virol. 2005 May;79(9):5786-98.

7.

Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.

Terauchi M, Koi H, Hayano C, Toyama-Sorimachi N, Karasuyama H, Yamanashi Y, Aso T, Shirakata M.

J Virol. 2003 Aug;77(15):8187-95.

8.
9.
10.

Effect of human cytomegalovirus on expression of MHC class I-related chains A.

Zou Y, Bresnahan W, Taylor RT, Stastny P.

J Immunol. 2005 Mar 1;174(5):3098-104.

11.

Antigen processing and presentation by human trophoblast-derived cell lines.

Gobin SJ, Wilson L, Keijsers V, Van den Elsen PJ.

J Immunol. 1997 Apr 15;158(8):3587-92.

PMID:
9103419
12.

HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.

Ulbrecht M, Hofmeister V, Yüksekdag G, Ellwart JW, Hengel H, Momburg F, Martinozzi S, Reboul M, Pla M, Weiss EH.

Hum Immunol. 2003 Feb;64(2):231-7.

PMID:
12559625
13.

The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.

Hewitt EW, Gupta SS, Lehner PJ.

EMBO J. 2001 Feb 1;20(3):387-96.

14.
15.

Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.

Johnson DC, Hegde NR.

Curr Top Microbiol Immunol. 2002;269:101-15. Review.

PMID:
12224504
16.

Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.

Pizzato N, Garmy-Susini B, Le Bouteiller P, Lenfant F.

J Reprod Immunol. 2004 Jun;62(1-2):3-15.

PMID:
15288176
17.

NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.

Falk CS, Mach M, Schendel DJ, Weiss EH, Hilgert I, Hahn G.

J Immunol. 2002 Sep 15;169(6):3257-66.

18.

Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells.

Schust DJ, Hill AB, Ploegh HL.

J Immunol. 1996 Oct 15;157(8):3375-80.

PMID:
8871634
19.

Interferon-gamma rescues HLA class Ia cell surface expression in term villous trophoblast cells by inducing synthesis of TAP proteins.

Rodriguez AM, Mallet V, Lenfant F, Arnaud J, Girr M, Urlinger S, Bensussan A, Le Bouteiller P.

Eur J Immunol. 1997 Jan;27(1):45-54.

PMID:
9021997
20.

Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation.

Copeman J, Han RN, Caniggia I, McMaster M, Fisher SJ, Cross JC.

Biol Reprod. 2000 Jun;62(6):1543-50.

PMID:
10819754

Supplemental Content

Support Center